胡海波,黄浩佳,栗政伟,吕建华,潘湘斌

• 1:国家心血管病中心北京协和医学院中国医学科学院阜外医院结构性心脏病中心

摘要(Abstract)：

低位卵圆孔未闭（PFO）是指PFO封堵术中PFO开口位置偏低，其左心房面开口距离二尖瓣房间隔侧根部距离小于9 mm的一种少见类型PFO。对于低位PFO目前临床上常用的双盘式PFO封堵器其最小型号（18 mm/18 mm）放置后封堵器边缘也会触碰到二尖瓣，导致二尖瓣反流或瓣叶磨蚀风险增加，一般术中遇到此情况只能放弃封堵。本病例报道采用Amplatzer ADOⅡ封堵器介入封堵低位PFO的成功病例，为这种少见类型PFO的介入封堵提供了新的思路和策略。

关键词(KeyWords)： 卵圆孔未闭;二尖瓣反流;介入封堵

Abstract:

Keywords:

基金项目(Foundation): 中央高水平医院临床科研业务费项目（2022-GSP-GG-18）

作者(Author): 胡海波,黄浩佳,栗政伟,吕建华,潘湘斌

参考文献(References)：

• [1] S?ndergaard L，Kasner SE，Rhodes JF,et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[J]. N Engl J Med,2017,377(11):1033-1042. DOI：10.1056/NEJMoa1707404.
• [2] Mas JL，Derumeaux G，Guillon B，et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J].N Engl J Med,2017,377(11):1011-1021. DOI：10.1056/NEJMoa1705915.
• [3] Saver JL，Carroll JD，Thaler DE,et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J].N Engl J Med,2017,377(11):1022-1032. DOI：10.1056/NEJMoa1610057.
• [4] Lee PH，Song JK，Kim JS,et al. Cryptogenic stroke and highrisk patent foramen ovale：the DEFENSE-PFO trial[J]. J Am Coll Cardiol,2018,71(20):2335-2342. DOI：10.1016/j.jacc.2018.02.046.
• [5]张玉顺，蒋世良，朱鲜阳.卵圆孔未闭相关卒中预防中国专家指南[J].心脏杂志，2021，33(1)：1-10. DOI：10.12125/j.chj.202101022.
• [6] Kuijpers T，Spencer FA，Siemieniuk RAC，et al. Patent foramen ovale closure，antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline[J]. BMJ,2018,362:k2515.DOI：10.1136/bmj.k2515.
• [7] MesséSR，Gronseth GS，Kent DM，et al. Practice advisory update summary：patent foramen ovale and secondary stroke prevention：report of the Guideline Subcommittee of the American Academy of Neurology[J]. Neurology,2020,94(20):876-885. DOI：10.1212/WNL.0000000000009443.
• [8] Pristipino C，GermonpréP，Toni D，et al. European position paper on the management of patients with patent foramen ovale.PartⅡ-Decompression sickness，migraine，arterial deoxygenation syndromes and select high-risk clinical conditions[J]. Eur Heart J,2021,42(16):1545-1553. DOI：10.1093/eurheartj/ehaa1070.
• [9] Stortecky S，da Costa BR，Mattle HP,et al. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism：a network meta-analysis[J]. Eur Heart J,2015，36(2):120-128. DOI：10.1093/eurheartj/ehu292.
• [10] Sigusch HH，Zimmermann B，Kuntze T，et al. Cardiac tamponade following aortic root erosion by an Amplatzer PFOOccluder in a 41-year-old woman：only a matter of sizing?[J].J Cardiol Cases,2020,23(3):123-126. DOI：10.1016/j.jccase.2020.10.014.
• [11] Amin Z,Hijazi ZM,Bass J,et al. PFO closure complications from the AGA registry[J]. Catheter Cardiovasc Interv,2008,72(1):74-79. DOI：10.1002/ccd.21582.
• [12] Kibler M，Marzak H，Jesel L，et al. High-grade atrioventricular block occurring during percutaneous closure of patent foramen ovale：a case report[J]. Eur Heart J Case Rep,2020,4(4):1-5. DOI：10.1093/ehjcr/ytaa141.
• [13] Krasniqi N，Roth J，Siegrist PT，et al. Percutaneous closure of patent foramen ovale and valvular function--effect of the amplatzer occluder[J]. J Invasive Cardiol,2012,24(6):274-277.
• [14] W?hrle J，Kochs M，Spiess J，et al. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies[J]. Circulation,2009,119(23):3002-3008. DOI：10.1161/CIRCULATIONAHA.109.851014.
• [15]黄浩佳，胡海波.应用ADOⅡ封堵器经皮介入治疗卵圆孔未闭封堵术后残余分流1例[J].中国介入心脏病学杂志，2022,30(9):709-710. DOI：10.3969/j.issn.1004-8812.2022.09.014.
• [16]张辉，胡海波，吕建华，等.经肱动脉入路介入治疗外科瓣膜置换术后瓣周漏[J].中华心血管病杂志，2021,49(5):467-473. DOI：10.3760/cma.j.cn112148-20210329-00278.
• [17] Cen H，Peng B，Li J，et al. Efficacy and safety of the Amplatzer Duct Occluder II for ventricular septal defect closure：a meta-analysis[J]. Kardiol Pol,2021,79(4):401-409.DOI：10.33963/KP.15762.